Across India, people recognise the scenario when someone has a seizure – a person suddenly collapses, the body stiffens, limbs jerk, and breathing sounds unfamiliar. Panic spreads instantly: people ...

Seizures are a complication that might arise after a stroke and their occurrence can happen from days to months and even years after the stroke event. A stroke causes blood flow interruption which ...

TREATABLE ARE DEFINITELY MAKING A COMEBACK. WE HAVE A NEW WARNING TONIGHT ABOUT YOUNG CHILDREN AND FLU SHOTS. THE FDA IS SAYING NOW THAT IT WANTS MANUFACTURERS TO ADD THE RISK FOR SEIZURES TO THAT ...

University of Virginia School of Medicine researchers have revealed how the popular, low-carb ketogenic diet protects against epilepsy seizures and possibly neurodegenerative diseases such as ...

A long-running debate over Tamiflu’s safety in children may finally be settled. Researchers found that influenza, not the antiviral medication, was linked to serious neuropsychiatric events like ...

A new study suggests temporal lobe epilepsy may be linked to early aging of certain brain cells. When researchers removed these aging cells in mice, seizures dropped, memory improved, and some animals ...

In what Ceribell is hailing as a first of its kind, the company received a 510(k) clearance from the FDA for its Clarity algorithm in detecting electrographic seizures in preterm infants as well as in ...

For more than 40 years, Margot has suffered from epileptic seizures, which she describes as “unforgettable.” Ever since she was a child, these seizures have made her feel like she has a “special link” ...

Epilepsy is a common neurological disorder that affects millions of people worldwide. Characterized primarily by seizures, epilepsy can present in a variety of ways depending on the individual and the ...

SK Biopharmaceutical’s Xcopri (cenobamate) met the bar in a phase 3 trial that could support the company’s ambitions of building a blockbuster with an expansion into another seizures subtype. Now, ...

A new drug candidate has shown impressive results in a mid-stage clinical trial for drug-resistant epilepsy, raising hopes for patients who continue to suffer seizures despite being on multiple ...

Praxis Precision Medicines has reported a 56.3% median reduction in seizure frequency from baseline in a midphase trial, encouraging the biotech to push ahead with phase 2/3 plans despite almost a ...